India's Emcure Pharma gains on Q2 profit, revenue rise
08/11/2024 04:09
** Shares of Emcure Pharmaceuticals EMCU.NS rise 5% to
1,511 rupees; set for second straight week of gains
** Co's Q1 consol net profit and rev from ops rise 40% and
20% y/y, respectively, aided by strong growth in international
businesses, especially in Canada
** Stock up 6% so far this week, eyes best weekly gain since
week ended Aug. 23
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees